Latrepirdine

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Latrepirdine
Accession Number
DB11725
Type
Small Molecule
Groups
Investigational
Description

Latrepirdine has been investigated for the treatment of Alzheimer's Disease and Huntington's Disease.

Structure
Thumb
Synonyms
  • Dimebon
Categories
UNII
OD9237K1Z6
CAS number
3613-73-8
Weight
Average: 319.452
Monoisotopic: 319.204847817
Chemical Formula
C21H25N3
InChI Key
JNODQFNWMXFMEV-UHFFFAOYSA-N
InChI
InChI=1S/C21H25N3/c1-15-4-7-20-18(12-15)19-14-23(3)10-9-21(19)24(20)11-8-17-6-5-16(2)22-13-17/h4-7,12-13H,8-11,14H2,1-3H3
IUPAC Name
5-(2-{2,8-dimethyl-1H,2H,3H,4H,5H-pyrido[4,3-b]indol-5-yl}ethyl)-2-methylpyridine
SMILES
CN1CCC2=C(C1)C1=CC(C)=CC=C1N2CCC1=CC=C(C)N=C1

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
PathwayCategory
Latrepirdine H1-Antihistamine ActionDrug action
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Human Metabolome Database
HMDB0240240
PubChem Compound
197033
PubChem Substance
347828086
ChemSpider
170644
BindingDB
50305261
ChEBI
92976
ChEMBL
CHEMBL589390
Wikipedia
Latrepirdine

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedNot AvailableAlzheimer's Disease (AD) / Huntington's Disease (HD)4
1CompletedNot AvailableHealthy Volunteers1
1CompletedBasic ScienceAlzheimer's Disease (AD) / Huntington's Disease (HD)1
1CompletedTreatmentAlzheimer's Disease (AD)1
1CompletedTreatmentAlzheimer's Disease (AD) / Huntington's Disease (HD)4
1CompletedTreatmentHepatic Failure1
1, 2CompletedTreatmentHuntington's Disease (HD)1
2CompletedTreatmentAlzheimer's Disease (AD)1
2CompletedTreatmentHuntington's Disease (HD)1
2TerminatedTreatmentAlzheimer's Disease (AD)1
3CompletedTreatmentAlzheimer's Disease (AD)3
3CompletedTreatmentHuntington's Disease (HD)1
3TerminatedTreatmentAlzheimer's Disease (AD)4
3TerminatedTreatmentHuntington's Disease (HD)1
3TerminatedTreatmentModerate to Severe Alzheimer1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0171 mg/mLALOGPS
logP3.52ALOGPS
logP3.41ChemAxon
logS-4.3ALOGPS
pKa (Strongest Basic)7.17ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area21.06 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity100.72 m3·mol-1ChemAxon
Polarizability38.6 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as n-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 1-position.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Indoles and derivatives
Sub Class
N-alkylindoles
Direct Parent
N-alkylindoles
Alternative Parents
3-alkylindoles / Methylpyridines / Aralkylamines / Substituted pyrroles / Benzenoids / Heteroaromatic compounds / Trialkylamines / Azacyclic compounds / Organopnictogen compounds / Hydrocarbon derivatives
Substituents
3-alkylindole / N-alkylindole / Indole / Methylpyridine / Aralkylamine / Pyridine / Substituted pyrrole / Benzenoid / Pyrrole / Heteroaromatic compound
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
Not Available

Drug created on October 20, 2016 14:42 / Updated on September 02, 2019 19:30